8-K: Kimberly-Clark Reports Mixed Q3 Results, Reaffirms 2024 Profit Outlook

Kimberly-Clark's third quarter results show a 1% organic sales growth despite a 4% decrease in net sales, driven by strong in-market execution and cost management.

Summary

• Kimberly-Clark reported a 4% decrease in net sales to $5.0 billion for the third quarter of 2024, but achieved a 1% organic sales growth.
• The company's reported gross margin was 36.0%, while the adjusted gross margin was 36.7%, a 90 basis point increase year-over-year.
• Diluted earnings per share were $2.69, which included a $1.34 gain from the sale of the PPE business, while adjusted earnings per share were $1.83, a 5% increase year-over-year.
• The company experienced a negative impact of approximately 3% from foreign currency translation and 1% from the divestiture of the K-C Professional PPE business.
• Organic sales growth was driven by a 1% increase in price, while volume and mix were in line with the previous year.
• Year-to-date, sales decreased by 2% to $15.1 billion, but organic sales grew by 4%.
• The company returned $2.0 billion to shareholders through dividends and share repurchases.
• Total debt was $7.5 billion as of September 30, 2024, down from $8.0 billion at the end of 2023.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the company's organic sales growth, improved margins, and reaffirmed profit outlook, but tempered by the decline in net sales and currency headwinds.

Positives

• The company achieved organic sales growth of 1% in the third quarter, indicating underlying strength in its core business.
• Adjusted gross margin improved by 90 basis points, demonstrating effective cost management and productivity gains.
• Adjusted earnings per share increased by 5%, showcasing the company's ability to drive profitability.
• The company's Powering Care strategy is accelerating innovation and reducing costs.
• Kimberly-Clark returned $2.0 billion to shareholders through dividends and share repurchases.
• The company's debt decreased from $8.0 billion to $7.5 billion since the end of 2023.

Negatives

• Net sales decreased by 4% in the third quarter, primarily due to foreign currency translation and divestitures.
• The company experienced a 1% decline in organic sales in North America.
• The Consumer Tissue segment saw a 1% decline in organic sales, driven by retailer inventory reductions in North America.
• K-C Professional sales decreased by 10% due to divestitures and unfavorable currency impacts.
• The company faced a negative impact of approximately 3% from foreign currency translation on sales.
• The company's reported net sales are expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures for the full year.

Risks

• The company is exposed to fluctuations in foreign currency exchange rates, particularly in hyperinflationary economies.
• The company faces risks related to supply chain disruptions and input cost inflation.
• The company's performance is subject to changes in customer preferences and competitive pressures.
• The company's 2024 outlook is subject to change given the macro environment.
• The company's transformation initiative could face disruptions or delays.
• The company is exposed to risks related to war in Ukraine and other regional instabilities.

Future Outlook

The company expects organic net sales to grow between 3%-4% for 2024, with adjusted operating profit and adjusted earnings per share growing at a mid-to-high teens percentage rate on a constant-currency basis. Reported net sales are expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures. Reported operating profit and reported earnings per share are now expected to be negatively impacted by approximately 650 basis points from currency translation.

Management Comments

• Kimberly-Clark Chairman and CEO, Mike Hsu, stated that the third quarter results reflect strong execution across the business as the company transforms its organization.
• Hsu also mentioned that the company is accelerating its innovation pipeline and reducing costs to deliver higher-quality consumer solutions.
• Hsu noted that the company is on track to deliver strong operating profit, margin, and EPS growth in 2024 while investing to maintain business momentum into 2025.

Industry Context

Kimberly-Clark's results reflect a mixed performance in the consumer goods sector, with strong productivity gains offset by challenges in sales due to currency fluctuations and divestitures. The company's focus on innovation and cost management aligns with industry trends aimed at improving profitability and market share in a competitive environment.

Comparison to Industry Standards

• Procter & Gamble (PG) and Unilever (UL) are key competitors in the consumer goods space. Kimberly-Clark's 1% organic sales growth is lower than some of its peers, but its focus on productivity and cost management is in line with industry best practices.
• The 90 basis point improvement in adjusted gross margin is a positive sign, but it needs to be compared to the margin performance of companies like P&G and Unilever to assess its relative strength.
• Kimberly-Clark's divestiture of the PPE business is a strategic move to focus on core consumer brands, similar to how other companies in the sector are streamlining their portfolios.
• The company's debt reduction from $8.0 billion to $7.5 billion is a positive step, but its debt levels should be compared to those of its competitors to assess its financial health.

Stakeholder Impact

• Shareholders will be impacted by the company's financial performance and the return of capital through dividends and share repurchases.
• Employees may be affected by the company's transformation initiative and cost-cutting measures.
• Customers will benefit from the company's focus on innovation and higher-quality consumer solutions.
• Suppliers may be impacted by changes in the company's supply chain and procurement strategies.

Next Steps

• The company will host a live Q&A session with investors and analysts on October 22, 2024.
• Supplemental materials will be available on the company's website.

Key Dates

Keywords

organic sales growth, gross margin, earnings per share, divestiture, currency translation, productivity, consumer tissue, personal care, K-C Professional, transformation initiative